Furusako
Seiji Furusako, Tokai-Shi JP
Patent application number | Description | Published |
---|---|---|
20110163571 | VEHICLE SIDE SECTON STRUCTURE - A vehicle side section structure that is capable of a required stiffness and enables a reduction in weight of a roof side section is provided. A roof side rail that structures a vehicle side section structure is provided with: a roof outer panel that has length in a vehicle front-rear direction and is opened inward of the vehicle, and has a pair of upper and lower flanges; and a roof side frame member that is joined to the pair of upper and lower flanges of the roof outer panel at a pair of upper and lower flanges. The roof side frame member has, between the upper and lower flanges, an outward protruding portion that is protruded in a vehicle outward direction and an inward protruding portion | 07-07-2011 |
Seiji Furusako, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20130168371 | LASER WELDING METHOD - At a plurality of welding positions in an overlap portion of a plurality of members including a high-tensile steel sheet whose carbon content is 0.07 weight % or more, first beads ( | 07-04-2013 |
Shoji Furusako, Shizuoka JP
Patent application number | Description | Published |
---|---|---|
20090029396 | Assay kit and antibody for human low molecular weight CD14 - The present invention provides an antibody prepared using a peptide as an antigen, the peptide having 8 to 30 amino acid residues selected from an amino acid sequence at positions 1 to 68 of human high-molecular-weight CD14, or an antibody that binds to a peptide having a specific amino acid sequence at a position among the positions 1 to 68. An assay kit for human low-molecular-weight CD14 using the antibody and an assay method of the present invention, preferably a sandwich method, are able to quantitatively or qualitatively determine human low-molecular-weight CD14 with high sensitivity and specificity in a simple manner, so that they are useful for the diagnosis of a patient suffering from sepsis. | 01-29-2009 |
20090203052 | NOVEL SOLUBLE CD14 ANTIGEN - There are provided a soluble CD14 antigen which is a novel in vivo protein useful as a marker for diagnosing sepsis and has the following characteristic features 1) to 3): | 08-13-2009 |
Shoji Furusako, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20080286290 | Anti-Cd14 Antibody Fusion Protein - A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided. | 11-20-2008 |
20090041783 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: | 02-12-2009 |
20090092612 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: | 04-09-2009 |
20110217318 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: | 09-08-2011 |
20120277412 | ANTI-CD14 ANTIBODY FUSION PROTEIN - A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided. | 11-01-2012 |
20130095120 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: a) It specifically binds to human platelet membrane glycoprotein VI (GPVI); b) The function to activate a platelet and/or the function to induce a thrombocytopenia in vivo are low; and c) It at least partially depletes GPVI on the platelet membrane by contacting with a platelet. | 04-18-2013 |
20140044723 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: a) It specifically binds to human platelet membrane glycoprotein VI (GPVI); b) The function to activate a platelet and/or the function to induce a thrombocytopenia in vivo are low; and c) It at least partially depletes GPVI on the platelet membrane by contacting with a platelet. | 02-13-2014 |
20140050727 | ANTI-CD14 ANTIBODY FUSION PROTEIN - A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided. | 02-20-2014 |
Tatsuo Furusako, Yokohama-Shi JP
Patent application number | Description | Published |
---|---|---|
20090100822 | INTEGRATED GASIFICATION COMBINED CYCLE AND THE CONTROL METHOD - A gasification unit provided with a gasification furnace | 04-23-2009 |